Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MBII

Marrone Bio Innovations (MBII) Stock Price, News & Analysis

Marrone Bio Innovations logo

About Marrone Bio Innovations Stock (NASDAQ:MBII)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$0.80
$0.80
50-Day Range
$0.80
$0.80
52-Week Range
$0.55
$1.55
Volume
38 shs
Average Volume
919,497 shs
Market Capitalization
$145.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

Remove Ads
Receive MBII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marrone Bio Innovations and its competitors with MarketBeat's FREE daily newsletter.

MBII Stock News Headlines

Upstream Bio Inc
Upstream Bio Inc (UPB)
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Man shot, killed by Olive Branch SWAT team
See More Headlines

MBII Stock Analysis - Frequently Asked Questions

Marrone Bio Innovations, Inc. (NASDAQ:MBII) issued its earnings results on Wednesday, November, 10th. The basic materials company reported ($0.03) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.03). The basic materials company earned $9.86 million during the quarter, compared to analyst estimates of $10.79 million. Marrone Bio Innovations had a negative trailing twelve-month return on equity of 70.87% and a negative net margin of 47.07%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Marrone Bio Innovations investors own include ObsEva (OBSV), Amyris (AMRS), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Rexahn Pharmaceuticals (REXN), Plug Power (PLUG) and Denali Therapeutics (DNLI).

Company Calendar

Last Earnings
11/10/2021
Today
3/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Agricultural Chemicals
Sub-Industry
N/A
Current Symbol
NASDAQ:MBII
Fax
N/A
Employees
153
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-16,550,000.00
Pretax Margin
-47.12%

Debt

Sales & Book Value

Annual Sales
$44.31 million
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
4.69

Miscellaneous

Free Float
173,259,000
Market Cap
$145.56 million
Optionable
Not Optionable
Beta
0.36

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:MBII) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners